申请人:Baxter Ellen
公开号:US20080194624A1
公开(公告)日:2008-08-14
The present invention is directed to 2-amino-quinoline derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the invention are inhibitors of β-secretase, also known as β-site cleaving enzyme and BACE, BACE1, Asp2 and memapsin2.
本发明涉及2-氨基喹啉衍生物,含有它们的药物组合物以及它们在治疗阿尔茨海默病(AD)及相关疾病中的应用。该发明的化合物是β-分泌酶的抑制剂,也称为β-位点裂解酶和BACE、BACE1、Asp2和memapsin2。